ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Dermatology"

  • Abstract Number: 1956 • ACR Convergence 2024

    Artificial Intelligence Enhanced Analysis of Nailfold Capillaries by Dermatoscopy in Rheumatology Centers

    Genessis Maldonado1, Eduardo Ramos-ibañez2, Borja del Carmelo Gracia-Tello3, Radic Mislav4 and Tracy Frech1, 1Vanderbilt University Medical Center, Nashville, TN, 2University of Zaragoza, Zaragoza, Spain, 3Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain, 4University Hospital of Split, Split, Croatia

    Background/Purpose: The use of dermatoscopes in rheumatology has been established for several years. However, the application of artificial intelligence for the detection of abnormalities in…
  • Abstract Number: 1977 • ACR Convergence 2024

    Three-dimensional Stereophotogrammetry Has Utility in Tracking Upper Eyelid Involvement and Overall Disease Worsening in Patients with Craniofacial Localized Scleroderma

    Tyler Cepica1, Jennifer Foster2, Priya Sarlashkar2, Rami Hallac3 and Heidi Jacobe2, 1University of Texas Southwestern Medical School, Benbrook, TX, 2The University of Texas Southwestern Medical Center, Department of Dermatology, Dallas, TX, 3The University of Texas Southwestern Medical Center, Department of Pastic Surgery, Dallas, TX

    Background/Purpose: Craniofacial localized scleroderma’s (LoS) indolent and subtle course poses challenges in quantifying disease progression. Traditional serial photography and the Localized Scleroderma Cutaneous Assessment Tool…
  • Abstract Number: 0093 • ACR Convergence 2024

    Overexpression of Epidermal Ifnk Promotes Systemic CD8+ T Cell Maturation After UV-exposure

    Benjamin Klein1, Kelsey E. McNeely2, Debbie Colesa2, Yiqing Gao2, Nguyen Thi Kim Nguyen2, Johann Gudjonsson1 and J. Michelle Kahlenberg1, 1University of Michigan, Ann Arbor, MI, 2University of Michigan Michigan Medicine, Ann Arbor, MI

    Background/Purpose: Skin involvement is the most common organ manifestation in systemic lupus erythematosus (SLE), and exacerbation of cutaneous lupus (CLE) can precede systemic disease flares.…
  • Abstract Number: 2153 • ACR Convergence 2024

    Construct Validity of the IDEOM Musculoskeletal Questionnaire (IDEOM MSK-Q) Using Data from the Cohort for Psoriasis and Psoriatic Arthritis Registry (COPPAR)

    Lourdes Perez Chada1, Ruogu Li2, vivi feathers2, Kumiko Schnock2, Helen Early2, Grace Carter2, Neda Shahriari2, Arianna Zhang2, Jing Cui3, Michael Weinblatt4, Nancy Shadick2, Alice Gottlieb5 and Joseph Merola6, 1Harvard Medical School, Wayland, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham Women's Hospital, Boston, MA, 4Brigham and Women's Hospital/ Harvard Medical School, Waban, MA, 5Icahn School of Medicine at Mount Sinai, Department of Dermatology, Seattle, WA, 6UT Southwestern Medical Center, Newton, MA

    Background/Purpose: Patients with psoriasis often present with musculoskeletal (MSK) symptoms, yet validated instruments to measure MSK symptoms in this population are limited. The IDEOM MSK-Q…
  • Abstract Number: 0328 • ACR Convergence 2024

    IFI27 Is Differentially Upregulated in Anti-MDA5 Dermatomyositis and Correlates with the Presence of Interstitial Lung Disease

    Melissa Leeolou1, Lorinda Chung2, Kavita Sarin3 and david fiorentino4, 1Stanford University School of Medicine, Redwood City, CA, 2Stanford University, Woodside, CA, 3Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, 4Department of Dermatology, Stanford University School of Medicine, Stanford, CA, Palo Alto, CA

    Background/Purpose: Type I interferon (IFN) plays a role in the pathogenesis of dermatomyositis (DM) and correlates with measures of disease activity.  Melanoma differentiation-associated gene 5…
  • Abstract Number: 2320 • ACR Convergence 2024

    Nailfold Videocapillaroscopy Findings in Patients with Psoriatic Disease: Is There a Distinctive Psoriatic Pattern?

    Eduardo Briones-García1, Tatiana Sofía Rodríguez-Reyna2, Eduardo Martin Nares2, Guillermo A Guaracha-Basañez3 and Iris Paola García Herrera4, 1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Immunology and Rheumatology Department., Ciudad de México, Distrito Federal, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 3Instituto Nacional de Ciencias Medicas y Nutricion “Salvador Zubirán”, Mexico City, Distrito Federal, Mexico, 4Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    Background/Purpose: The utility of nailfold videocapillaroscopy (NVC) in conditions such as systemic sclerosis and primary Raynaud´s phenomenon is well known. Whether patients with psoriatic disease…
  • Abstract Number: 0594 • ACR Convergence 2024

    Real-world Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-17 Inhibitors: A 16-week Multicenter Retrospective Review

    Siddhartha Sood1, Alexander Rimke2, Brian Rankin3, Abrahim Abduelmula4, jorge Georgakopoulos4, Khalad Maliyar4, Ahmed Bagit5, Fernejoy Leung6, Alim Devani6, Ronald Vender7, Jensen Yeung4 and Vimal Prajapati3, 1Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada, 2Dermatology Research Institute, Calgary, AB, Canada, 3Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada, 4Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada, 5Temerty Faculty of Medicine, University of Toronto, Toronto, Canada, 6Skin Health & Wellness Centre, Calgary, AB, Canada, 7Division of Dermatology, Department of Medicine, McMaster University, Hamilton, Canada

    Background/Purpose: While biologic switching is common in routine clinical practice, limited information exists on switching within class from another IL-17i to bimekizumab. We conducted a…
  • Abstract Number: 2348 • ACR Convergence 2024

    Bimekizumab Efficacy and Safety Through 4 Years in Moderate to Severe Plaque Psoriasis: Long-Term Results from a Phase 3 Study and Open-Label Extension

    Diamant Thaçi1, Luis Puig2, Joseph F. Merola3, Denis Jullien4, Antonio Costanzo5, Maggie Wang6, Delphine Deherder7, José M. López Pinto8 and Mark Lebwohl9, 1Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Schleswig-Holstein, Germany, 2Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain, 3UT Southwestern Medical Center, Dallas, TX, 4Department of Dermatology, Hôpital Edouard Herriot, Hospices Civils de Lyon, University of Lyon, Lyon, France, 5Department of Dermatology, Humanitas Clinical and Research Centre, IRCCS, Rozzano, Milan, Italy, 6UCB Pharma, Morrisville, NC, 7UCB Pharma, Braine-l'Alleud, Belgium, 8UCB Pharma, Madrid, Spain, 9Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Clinical improvements through Week 152, with no unexpected safety findings, were previously reported with bimekizumab (BKZ) in the BE SURE phase 3 trial and…
  • Abstract Number: 0596 • ACR Convergence 2024

    Impact of a Multidisciplinary Rheumatology-Dermatology-Gastroenterology Center in the Management of Patients with Psoriatic Arthritis: Analysis of the First 5-years of Implementation

    Marina Sánchez-Lucas1, Camille Bourgeois1, Juan Molina-Collada2, Teresa Gonzalez-Hernandez1, Juan Carlos Nieto Gonzalez1, Amparo Lopez-Esteban1, Ofelia Baniandres1, Esther Chamorro de Vega1 and Isabel Castrejon3, 1Hospital Universitario Gregorio Marañón, Madrid, Spain, 2Hospital General Universitario Gregorio Marañón, Madrid, Spain, 3Hospital General Universitario Gregorio Marañon, Madrid, Spain

    Background/Purpose: Psoriatic arthritis (PsA) has a heterogenous clinical phenotype with manifestations in a number of different organs and systems. These include not only enthesitis, synovitis…
  • Abstract Number: 2640 • ACR Convergence 2024

    Comparative Safety and Use of Non-conventional Combination Targeted Therapy in Adults with Psoriatic Arthritis

    Alexander Wu1, Arianna Zhang2, Yujia Guo1, Jialing Liu1, Donghan Yang1, Lourdes Perez Chada3, Alexis Ogdie4, Jose Scher5 and Joseph Merola6, 1University of Texas Southwestern Medical Center, Dallas, 2Brigham and Women's Hospital, Boston, MA, 3Harvard Medical School, Wayland, MA, 4Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 5New York University School of Medicine, New York, NY, 6UT Southwestern Medical Center, Newton, MA

    Background/Purpose: Psoriatic arthritis is a chronic systemic inflammatory disorder with significant impacts on health and life quality. Achieving good disease control in psoriatic arthritis (PsA)…
  • Abstract Number: 0632 • ACR Convergence 2024

    Cutaneous Lupus Erythema and Scale Have Similar Six-month Trends Without Significant Impact from Race/ethnicity or Disease Subtype

    Tyler Cepica1, Lillian Xie2, Daniella Faden2, Caroline Stone3, Victoria Werth4 and Benjamin Chong5, 1University of Texas Southwestern Medical School, Benbrook, TX, 2University of Pennsylvania, Philadelphia, PA, 3University of Pennsylvania, Phiiladelphia, PA, 4Hospital of the University of Pennsylvania, Philadelphia, PA, 5The University of Texas Southwestern Medical Center, Department of Dermatology, Dallas, TX

    Background/Purpose: The Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) is a validated outcome measure designed to assess cutaneous lupus erythematosus (CLE) activity (CLASI-A)…
  • Abstract Number: 2655 • ACR Convergence 2024

    Diagnostic Challenges of Dermatomyositis: A Retrospective Study of Its Dermatologic Mimics and Misdiagnoses

    Aaron Bao1, Eleni Tiniakou2, Lisa Christopher-Stine3, Christopher Mecoli3, Jemima Albayda1, Julie Paik3, William Kelly4 and Jun Kang5, 1Johns Hopkins School of Medicine, Baltimore, MD, 2Johns Hopkins University, Lutherville Timonium, MD, 3Johns Hopkins University, Baltimore, MD, 4Johns Hopkins University, Hillsboro, NH, 5Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Dermatomyositis (DM) is often misdiagnosed due to its diverse clinical presentation. This study aimed to identify common dermatologic mimics of DM, characterize misdiagnosis rates…
  • Abstract Number: 0895 • ACR Convergence 2024

    Procoagulant Extracellular Vesicles in Patients with Livedo Reticularis

    Avital Baniel1, Cristina Ricco2, Rohan Dhiman3, Ahmed Eldaboush4, Caroline Stone4, Daniella Faden4, Luca Musante4, MIng-lin Liu4 and Victoria Werth5, 1Perelman School of Medicine, UPENN, Philadelphia, PA, 2university of pennsylvania, Philadelphia, 3University of Pennsylvania, Newport Coast, CA, 4University of pennsylvania, Philadelphia, PA, 5University of Pennsylvania, Wynnewood, PA

    Background/Purpose: Procoagulant activity is an important property of EVs. Connective tissue disease (CTD) patients with livedo reticularis (LR) are known for their procoagulant conditions. The…
  • Abstract Number: 0930 • ACR Convergence 2024

    The Common Form of the Inflammatory Skin Disease Hidradenitis Suppurativa Is Associated with Low Nicastrin Expression in Dermal Fibroblasts

    Kaitlin Williams, Beita Badiei, Hana Minsky and Luis Garza, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful nodules and abscesses in intertriginous areas. Despite its increasing prevalence, the etiology…
  • Abstract Number: 0988 • ACR Convergence 2024

    Antinuclear Antibody Positivity and Its Diagnostic Implications for Rheumatic Diseases in Dermatology Patients: A Comprehensive Single Center Analysis

    Yunjung Choi1, Myeung-Su Lee2 and Wan-Hee Yoo3, 1Jeonbuk National University Medical School, Deokjin-gu, Jeollabuk-do, Republic of Korea, 2Wonkwang University Hospital, Iksan, South Korea, 3CHONBUK NATIONAL UNIVERSITY HOSPITAL, JEONJU, Republic of Korea

    Background/Purpose: Cutaneous manifestations are common in rheumatic diseases and can be early indicators. This study investigates the prevalence of rheumatic diseases diagnosed through ANA (Antinuclear…
  • 1
  • 2
  • 3
  • …
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology